We stick to the IFCC reference method and the corresponding limits of 34 and 45 IU/L for F/M
See
http://www.ncbi.nlm.nih.gov/pubmed/12241021 and
http://www.ncbi.nlm.nih.gov/pubmed/12482620
Best regards, Bart
B.E.P.B. Ballieux PhD,
Clinical Biochemist
Endocrinology,
Department KCL, E2-P.
Leiden University Medical Centre,
P.O.box 9600,
2300RC Leiden
Tel: +3171-5262165/62278
Fax: +3171-5266753
email:
[log in to unmask]
P
Please consider the environment before printing this e-mail
Van: Clinical biochemistry discussion list [mailto:[log in to unmask]]
Namens Jordaan Marieke
Verzonden: dinsdag 13 oktober 2015 14:28
Aan: [log in to unmask]
Onderwerp: ALT reference ranges
Dear colleagues
It would be interesting to get an impression of the ALT reference range used in other laboratories.
NICE CG165 on Diagnosis and Management of Chronic Hepatitis B, published in June 2013 (http://www.nice.org.uk/guidance/cg165/evidence/cg165-hepatitis-b-chronic-full-guideline3)
makes reference to ALT a number of times, and bases important clinical decisions on “normal”, “abnormal” and “normalized” ALT levels, which they define as
greater than or equal to 30 IU/L for males and greater than or equal to 19 IU/L for females
There is some explanation of why these cutoffs were chosen on page 159:
With alcohol use and obesity now so common the impact of using these ALT reference ranges on diagnostic investigations could be very significant.
Harmony does not appear to have agreed a cutoff for ALT, unlike other LFT.
If you want to reply with your cutoff only, I will collate the responses for the mailbase.
Regards
Marieke
Dr Marieke Jordaan
Consultant Chemical Pathologist
Mid-Yorkshire Trust
Email:
[log in to unmask]
Tel: (01924) 317060 or ext 57060
PA, Diane Blakeston: (01924) 317056 or ext 57056
This e mail or any attachments to it may contain legally privileged or confidential data. You should not forward it to
anyone without reference to the Trusts Confidentiality and E Mail policies for guidance.
If you are not the intended recipient, please notify the author immediately by telephone or by replying to this e-mail and then delete all copies of the e-mail
on your system. If you are not the intended recipient, you must not use, disclose, distribute, copy, print or rely on this e-mail.
This email or any attachments to it may contain legally privileged or confidential data. You should not forward it to anyone without reference to the Trusts
Confidentiality and EMail policies for guidance. If you are not the intended recipient, please notify the author immediately by telephone or by replying to this e-mail and then delete all copies of the e-mail on your system. If you are not the intended recipient,
you must not use, disclose, distribute, copy, print or rely on this e-mail.
------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived
messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content. ACB Web Site
http://www.acb.org.uk Green Laboratories Work
http://www.laboratorymedicine.nhs.uk List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/